Sponsor:
Sanofi
Code:
NCT05669989
Conditions
Plasma Cell Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Isatuximab intravenous (IV)
Cemiplimab (SAR439684)
Dexamethasone
Lenalidomide
Pomalidomide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations